![Christopher Murray](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Christopher K.
Murray worked at ARIAD Pharmaceuticals, Inc. from 2004 to 2017, serving as Vice President-Technical Operations from 2013 to 2017.
Dr. Murray worked at Blueprint Medicines Corp.
from 2017 to 2025, serving as Chief Technical Operations & Quality Officer.
Dr. Murray completed undergraduate studies at Hope College in 1984 and graduate studies at The University of Chicago in 1990.
Laatste nieuws over Christopher Murray
Eerdere bekende functies van Christopher Murray
| Bedrijven | Functie | Einde |
|---|---|---|
| BLUEPRINT MEDICINES CORPORATION | Hoofd Techniek/Wetenschap/O&O | 01-04-2025 |
| ARIAD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-05-2017 |
Opleiding van Christopher Murray
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
79
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes small-molecule drugs for the treatment of cancer | Health Technology |
Hope College
 Hope College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Blueprint Medicines Corp.
 Blueprint Medicines Corp. BiotechnologyHealth Technology Develops cancer therapies that harness the growing understanding of the molecular blueprint of cancer | Health Technology |
